- Exchanges
- BSE, NSE
- Issue
- Book building
Krishna Institute of Medical Sciences IPO
₹996.95
+20.84% on listing
Listing-day close · NSE · 28 Jun 2021 · issue price ₹825
Krishna Institute of Medical Sciences’ ₹2,144 crore IPO was priced at ₹825 a share. It listed on the NSE on 28 Jun 2021 and closed its first day at ₹996.95, up 20.84% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹2,144 Cr
- Fresh issue
- ₹201 Cr
- Offer for sale
- ₹1,943 Cr
- Lot size
- 18 shares
- Minimum investment
- ₹14,850
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 2.52× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹6,602 Cr
- Promoter holding
- 46.81% → 38.84%
From the offer documents.
Listing
- Listing date
- 28 Jun 2021
- Issue price
- ₹825
- Open
- ₹1,009.00
- High
- ₹1,059.00
- Low
- ₹950.00
- Close
- ₹996.95
Listing day on the NSE. The close was +20.84% on the issue price.
KIMS share price todayFAQs
When did the Krishna Institute of Medical Sciences IPO open and close?
It opened on 16 Jun 2021 and closed on 18 Jun 2021.
What was the Krishna Institute of Medical Sciences IPO price?
The price band was ₹815–825 a share. The final issue price was ₹825.
What is the lot size and minimum investment?
One lot is 18 shares, ₹14,850 at ₹825 a share. Retail investors apply in whole lots.
How much did Krishna Institute of Medical Sciences raise?
₹2,144 crore: ₹201 crore of new shares and ₹1,943 crore offered by existing shareholders.
How many times was the Krishna Institute of Medical Sciences IPO subscribed?
2.52 times overall.
How did Krishna Institute of Medical Sciences list?
It listed on the NSE on 28 Jun 2021 at ₹1,009.00 and closed the day at ₹996.95, up 20.84% on the ₹825 issue price.
Who is the registrar of the Krishna Institute of Medical Sciences IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app